TD Cowen Upgrades Merck & Co to Outperform, Raises Price Target to $135
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Steve Scala has upgraded Merck & Co (NYSE:MRK) from Market Perform to Outperform and increased the price target from $125 to $135, indicating a positive outlook on the company's stock.

January 04, 2024 | 11:04 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Merck & Co has been upgraded by TD Cowen from Market Perform to Outperform with a raised price target from $125 to $135, suggesting a bullish stance on the stock.
Upgrades by analysts, especially from Market Perform to Outperform, typically signal a positive change in the company's outlook, which can lead to increased investor confidence and a potential rise in the stock price. The increase in the price target further reinforces the positive sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100